Back
KraneShares MSCI All China Hlth Care ETF Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
37
KURE
KraneShares MSCI All China Hlth Care ETF
Last Price:
15.43
Seasonality Move:
-2.76%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.KraneShares MSCI All China Hlth Care ETF Price Quote
$15.43
+0.36 (+0.06%)
(Updated: November 15, 2024 at 5:36 AM ET)
KraneShares MSCI All China Hlth Care ETF Key Stats
Sell
37
KraneShares MSCI All China Hlth Care ETF (KURE)
is a Sell
Day range:
$14.90 - $15.00
52-week range:
$12.91 - $20.51
Dividend yield:
0.75%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
3.8K
Avg. volume:
27.6K
1-year change:
-19.97%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does KraneShares MSCI All China Hlth Care ETF Make?
Data Unavailable
Is KraneShares MSCI All China Hlth Care ETF Growing As A Company?
Data Unavailable
KraneShares MSCI All China Hlth Care ETF Stock Price Performance
-
Did KraneShares MSCI All China Hlth Care ETF Stock Go Up Last Month?
KraneShares MSCI All China Hlth Care ETF share price went down by -7.32% last month -
Did KURE's Share Price Rise Over The Last Year?
KURE share price fell by -19.97% over the past 1 year
What Is KraneShares MSCI All China Hlth Care ETF 52-Week High & Low?
-
What Is KraneShares MSCI All China Hlth Care ETF’s 52-Week High Share Price?
KraneShares MSCI All China Hlth Care ETF has traded as high as $20.51 over the past 52 weeks -
What Is KraneShares MSCI All China Hlth Care ETF’s 52-Week Low Share Price?
KraneShares MSCI All China Hlth Care ETF has traded as low as $12.91 over the past 52 weeks
KraneShares MSCI All China Hlth Care ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy KraneShares MSCI All China Hlth Care ETF?
Data Unavailable
Is KraneShares MSCI All China Hlth Care ETF Cash Flow Positive?
Data Unavailable
KraneShares MSCI All China Hlth Care ETF Return On Invested Capital
Data Unavailable
KraneShares MSCI All China Hlth Care ETF Earnings Date & Stock Price
-
What Is KraneShares MSCI All China Hlth Care ETF's Stock Price Today?
A single share of KURE can be purchased today for 15.07 -
What Is KraneShares MSCI All China Hlth Care ETF’s Stock Symbol?
KraneShares MSCI All China Hlth Care ETF trades on the nysearca under the ticker symbol: KURE -
When Is KraneShares MSCI All China Hlth Care ETF’s Next Earnings Date?
The next quarterly earnings date for KraneShares MSCI All China Hlth Care ETF is scheduled on November 16, 2024 -
When Is KURE's next ex-dividend date?
KraneShares MSCI All China Hlth Care ETF's next ex-dividend date is December 18, 2023 -
How To Buy KraneShares MSCI All China Hlth Care ETF Stock?
You can buy KraneShares MSCI All China Hlth Care ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
KraneShares MSCI All China Hlth Care ETF Competitors
-
Who Are KraneShares MSCI All China Hlth Care ETF's Competitors?
Below is a list of companies who compete with KraneShares MSCI All China Hlth Care ETF or are related in some way:
KraneShares MSCI All China Hlth Care ETF Dividend Yield
-
What Is KURE Dividend Yield?
KraneShares MSCI All China Hlth Care ETF’s dividend yield currently is 0.75% -
What Is KraneShares MSCI All China Hlth Care ETF’s Payout Ratio?
KraneShares MSCI All China Hlth Care ETF’s payout ratio is 0% -
When Did KraneShares MSCI All China Hlth Care ETF Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is KraneShares MSCI All China Hlth Care ETF’s Dividend Per Share?
KraneShares MSCI All China Hlth Care ETF pays a dividend of $0.00 per share
KraneShares MSCI All China Hlth Care ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable